Primary Care Pulse: Recorded Live on February 23, 2021

Thank you to all who joined us live Primary Care Pulse on February 23, 2021. If you were not able to join us live, the sessions have been recorded and are available below.

Upcoming Virtual Programs
Join your clinician colleagues and expert faculty as they present the latest clinical insights and guidelines during a variety of upcoming virtual education opportunities, including Primary Care Pulse and PrimaryCareNOW. View our upcoming virtual conference schedule.

Virtual Programs


Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

12-12:30PM ET    CME/CE Accredited Session

Infectious Disease

Influenza: Your Questions Answered (February 2021)

Daniel A. Solomon, MD | Charles Vega, MD, FAAFP

 


Get your influenza questions answered during this live 30-minute Q&A session, hosted by primary care specialist Charles Vega, MD, FAAFP, and infectious disease specialist, Daniel Solomon, MD. The faculty will start the session with a brief discussion of a patient case and common questions they receive, followed by an open question and answer session from the audience for the remaining time. 

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine, Harvard Medical School, Boston, MA

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by an educational grant from Genentech, a member of the Roche Group

12:40-1:25PM ET    Non-CME Industry Theater

Cardiology

Primary Care Heart Failure Learning Module

 


Heart failure (HF) is a complex syndrome brought on by impairment of the structure or function of ventricular filling or blood ejection. These changes can significantly decrease quality of life, resulting in edema, dyspnea, and fatigue. The disease is widespread and progresses in severity, resulting in significant morbidity and mortality.

This course is built on the latest HF guidelines and seeks to help learners better understand this prevalent, serious disease. Topics include pathophysiology, etiology and epidemiology, morbidity and mortality, diagnosis through the use of biomarkers and other screening tools, impact of HF hospitalization, hospitalization care goals, and team-based care.

For more HF and cardiovascular disease education content, please see https://www.HallsofScience.com.

This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.

M-HFS-1397709 11/20

Sponsored by Novartis Pharmaceutical Corporation